428 related articles for article (PubMed ID: 37047329)
1. Mesoporous Silica Nanoparticles as a Potential Nanoplatform: Therapeutic Applications and Considerations.
Djayanti K; Maharjan P; Cho KH; Jeong S; Kim MS; Shin MC; Min KA
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047329
[TBL] [Abstract][Full Text] [Related]
2. Mesoporous silica nanoparticles for therapeutic/diagnostic applications.
Jafari S; Derakhshankhah H; Alaei L; Fattahi A; Varnamkhasti BS; Saboury AA
Biomed Pharmacother; 2019 Jan; 109():1100-1111. PubMed ID: 30551360
[TBL] [Abstract][Full Text] [Related]
3. Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery: an update.
Castillo RR; Lozano D; González B; Manzano M; Izquierdo-Barba I; Vallet-Regí M
Expert Opin Drug Deliv; 2019 Apr; 16(4):415-439. PubMed ID: 30897978
[TBL] [Abstract][Full Text] [Related]
4. In vivo bio-safety evaluations and diagnostic/therapeutic applications of chemically designed mesoporous silica nanoparticles.
Chen Y; Chen H; Shi J
Adv Mater; 2013 Jun; 25(23):3144-76. PubMed ID: 23681931
[TBL] [Abstract][Full Text] [Related]
5. Multifunctional mesoporous silica nanoparticles for biomedical applications.
Xu B; Li S; Shi R; Liu H
Signal Transduct Target Ther; 2023 Nov; 8(1):435. PubMed ID: 37996406
[TBL] [Abstract][Full Text] [Related]
6. A Review on Recent Technologies and Patents on Silica Nanoparticles for Cancer Treatment and Diagnosis.
Gupta A; Kushwaha SS; Mishra A
Recent Pat Drug Deliv Formul; 2020; 14(2):126-144. PubMed ID: 32928094
[TBL] [Abstract][Full Text] [Related]
7. Biosafety of mesoporous silica nanoparticles; towards clinical translation.
Lérida-Viso A; Estepa-Fernández A; García-Fernández A; Martí-Centelles V; Martínez-Máñez R
Adv Drug Deliv Rev; 2023 Oct; 201():115049. PubMed ID: 37573951
[TBL] [Abstract][Full Text] [Related]
8. A systemic review on development of mesoporous nanoparticles as a vehicle for transdermal drug delivery.
Kolimi P; Narala S; Youssef AAA; Nyavanandi D; Dudhipala N
Nanotheranostics; 2023; 7(1):70-89. PubMed ID: 36593800
[TBL] [Abstract][Full Text] [Related]
9. Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery.
Tang F; Li L; Chen D
Adv Mater; 2012 Mar; 24(12):1504-34. PubMed ID: 22378538
[TBL] [Abstract][Full Text] [Related]
10. Tailored Mesoporous Silica Nanoparticles for Controlled Drug Delivery: Platform Fabrication, Targeted Delivery, and Computational Design and Analysis.
She X; Chen L; Yi Z; Li C; He C; Feng C; Wang T; Shigdar S; Duan W; Kong L
Mini Rev Med Chem; 2018; 18(11):976-989. PubMed ID: 27145854
[TBL] [Abstract][Full Text] [Related]
11. A review on the latest developments of mesoporous silica nanoparticles as a promising platform for diagnosis and treatment of cancer.
Ahmadi F; Sodagar-Taleghani A; Ebrahimnejad P; Pouya Hadipour Moghaddam S; Ebrahimnejad F; Asare-Addo K; Nokhodchi A
Int J Pharm; 2022 Sep; 625():122099. PubMed ID: 35961417
[TBL] [Abstract][Full Text] [Related]
12. Mesoporous Silica Nanoparticles: Drug Delivery Vehicles for Antidiabetic Molecules.
Sarkar S; Ekbal Kabir M; Kalita J; Manna P
Chembiochem; 2023 Apr; 24(7):e202200672. PubMed ID: 36719179
[TBL] [Abstract][Full Text] [Related]
13. Mesoporous Silica Nanoparticles-Based Nanoplatforms: Basic Construction, Current State, and Emerging Applications in Anticancer Therapeutics.
Feng Y; Liao Z; Li M; Zhang H; Li T; Qin X; Li S; Wu C; You F; Liao X; Cai L; Yang H; Liu Y
Adv Healthc Mater; 2023 Jun; 12(16):e2201884. PubMed ID: 36529877
[TBL] [Abstract][Full Text] [Related]
14. Mesoporous Silica Platforms with Potential Applications in Release and Adsorption of Active Agents.
Chircov C; Spoială A; Păun C; Crăciun L; Ficai D; Ficai A; Andronescu E; Turculeƫ ȘC
Molecules; 2020 Aug; 25(17):. PubMed ID: 32825791
[TBL] [Abstract][Full Text] [Related]
15. Recent advancements in mesoporous silica nanoparticles towards therapeutic applications for cancer.
Li T; Shi S; Goel S; Shen X; Xie X; Chen Z; Zhang H; Li S; Qin X; Yang H; Wu C; Liu Y
Acta Biomater; 2019 Apr; 89():1-13. PubMed ID: 30797106
[TBL] [Abstract][Full Text] [Related]
16. Biomedical application of mesoporous silica nanoparticles as delivery systems: a biological safety perspective.
Hosseinpour S; Walsh LJ; Xu C
J Mater Chem B; 2020 Nov; 8(43):9863-9876. PubMed ID: 33047764
[TBL] [Abstract][Full Text] [Related]
17. Mesoporous silica nanoparticles in drug delivery and biomedical applications.
Wang Y; Zhao Q; Han N; Bai L; Li J; Liu J; Che E; Hu L; Zhang Q; Jiang T; Wang S
Nanomedicine; 2015 Feb; 11(2):313-27. PubMed ID: 25461284
[TBL] [Abstract][Full Text] [Related]
18. Mesoporous Silica Nanoparticles as a Prospective and Promising Approach for Drug Delivery and Biomedical Applications.
Pu X; Li J; Qiao P; Li M; Wang H; Zong L; Yuan Q; Duan S
Curr Cancer Drug Targets; 2019; 19(4):285-295. PubMed ID: 30520373
[TBL] [Abstract][Full Text] [Related]
19. Advances in Functionalized Mesoporous Silica Nanoparticles for Tumor Targeted Drug Delivery and Theranostics.
Zhang W; Liu M; Liu A; Zhai G
Curr Pharm Des; 2017; 23(23):3367-3382. PubMed ID: 27784244
[TBL] [Abstract][Full Text] [Related]
20. Mesoporous silica nanoparticles with organo-bridged silsesquioxane framework as innovative platforms for bioimaging and therapeutic agent delivery.
Du X; Li X; Xiong L; Zhang X; Kleitz F; Qiao SZ
Biomaterials; 2016 Jun; 91():90-127. PubMed ID: 27017579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
